现代快报讯（记者 ...

I am reversing my rating on Akero Therapeutics stock from Buy to Sell due to valuation concerns and a long-ish wait for ...

Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH ...

Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-cirrhotic MASH ...

The Lebanon and Western Boone cross country teams headed up to Lafayette on Saturday to compete in the Champ at the Amp Meet.

View the latest Equifax Inc. (EFX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Akero Therapeutics (AKRO) announced publication of 96-week final results from the Phase 2b HARMONY trial in The Lancet in adults with ...

Shares of Equifax Inc. EFX slid 2.06% to $248.07 Thursday, on what proved to be an all-around mixed trading session for the ...

View and compare FIG,BMRN,HOOD,CRWV,NVDA,NVDX,AMD,URA,NUKZ,AMZN,AMZU,MSFT,GOOG,RTX,EFX,JAZZ on Yahoo Finance.